https://charts.traderzeitung.de/phases/US02080L1026 string(1446) "{"isin":"US02080L1026","name":"Alpha Teknova Inc","stock_id_xnas":22560842,"stock_id_xnys":null,"generated_at":"2026-09-24 01:31:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":7.835,"close_at":"2026-09-21 14:12:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":8.35,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":6.5731},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":8.755,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":4.8503},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":8.76,"close_at":"2026-09-22 22:31:00","complete":true,"perf_pct":0.0571}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":8.91,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":1.7123},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":8.91,"close_at":"2026-09-23 23:58:00","complete":false,"perf_pct":0}]}]}"

Alpha Teknova Aktie News & Nachrichten

[WKN: A3CS7X | Symbol: TKNO]

Realtimekurs

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Alpha Teknova gefunden werden.

Alpha Teknova Nachrichtenticker öffnen

MT Newswires 17.09.2026 13:41 Uhr

Alpha Teknova Aktie News & Nachrichten

Artikel aus der Redaktion der Trader-Zeitung

Jefferies & Co. nimmt Alpha Teknova mit Buy-Rating und Kursziel von 9 USD auf

BTIG stuft Alpha Teknova von Neutral auf Buy hoch, Kursziel ist 8 USD

Roth Capital bewertet Alpha Teknova neu mit Buy und Kursziel 7 USD